Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes The year 2020 has been marred by […]
Blog
Coronavirus: scientific research needs an urgent rescue plan
On March 19, President Emmanuel Macron said “the Covid-19 crisis reminds us of the vital nature of scientific research and […]
Angiosafe – Covid-19
Diabetic patients are known to be at increased risk of infections. This is especially the case for viral infections and […]
Top Tips for Working from Home During the Coronavirus Pandemic
The global spread of COVID-19 is keeping people at home. Much of the world is on lockdown, and even in […]
CoviDIAB
CoviDIAB Personalized support during the coronavirus epidemic For diabetic patients confined during the COVID-19 epidemic, the AP-HP, in partnership with […]
Jean-Pierre Riveline publishes in JCEM
Exposure to Glucocorticoids in the First Part of Fetal Life is Associated with Insulin Secretory Defect in Adult Humans Type […]
Louis Potier publishes in Diabetes Care
Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes Lower-extremity amputation (LEA) is a major […]
NR, Metabolism & Inflammation meeting @ IMMEDIAB
On the 27th of November the IMMEDIAB Lab is organising a themed meeting on Nuclear Receptors, Metabolism and Inflammation, all […]
Frédéric Fumeron publishes in Mol Metab
New roles for prokineticin 2 in feeding behavior, insulin resistance and type 2 diabetes: Studies in mice and humans The […]
We’re Recruiting!
The IMMEDIAB Lab is recruiting a new postdoc, find the deets below!
